TAK
Takeda Pharmaceutical Co Ltd
$16.03
+0.12 (+0.72%)
Short interest:
0.34% of float · ▲ +10.0% MoM · 1.6 days cover
3 Up Days
Indicators
Price
Panels
Event markers
Price & Indicators
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$16.03
Open$15.97
Day$15.84–16.04
52W$12.99–18.90
Avg vol 30d2.8M
Short int5.4M · 1.6d
Short vol70%
Last earningsDec 31, 2022
DataJan 2020–Jun 2026
Equibles Rating
blended score
Overall
Buy
Technical · trend & momentum
Buy
+
Price vs 200-day avg · +0% above
◦
50 / 200-day cross
no cross
+
Price vs 200-day avg
+0% above
◦
Price vs 50-day avg
−1% below
◦
RSI (14)
53 · neutral
+
MACD trend
positive
◦
52-week position
51% · mid-range
Sentiment · smart money
Bullish
+
Institutional flow · +3% holders QoQ · +57 funds added
◦
Trend (MA cross)
50d $16 › 200d $16 — 50d above 200d
+
Institutional flow
+3% holders QoQ · +57 funds added
◦
Insider flow
No net insider activity over 90 days
−
Short interest
0.34% of float · ▲ +10.0% MoM · 1.6 days cover
◦
Volume signal
Volume near normal
+
Institution breadth
360 holders — near 3-yr high, broad support
Fundamentals
Limited data
Not enough data for a confident read
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Key facts
Market Cap
$50.65B
Shares
1,557,765,596
CIK
1395064
CUSIP
874060205
13F Activity (30d)
3 filings
2 filers
Website
Visit website
Up next
FQ2-27 quarter ends
~Sep 30, 2026
Est
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
no cross
Neutral
Price vs 200-day avg
+0% above
Bullish
Price vs 50-day avg
−1% below
Neutral
RSI (14)
53 · neutral
Neutral
MACD trend
positive
Bullish
52-week position
51% · mid-range
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $16 › 200d $16 — 50d above 200d
Institutional flow
Accumulating
+3% holders QoQ · +57 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.34% of float · ▲ +10.0% MoM · 1.6 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
360 holders — near 3-yr high, broad support
Price context
position in its 52-week range
52-wk low $13
Now $16 · 51%
52-wk high $19
vs 200-day avg +0%
vs 50-day avg -1%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Drug Manufacturers - Specialty & Generic — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
TAK
this stock
Takeda Pharmaceutical Co Ltd
|
$50.65B | +2.8% | — | — | 0.3% |
|
GALDY
Galderma Group AG/ADR
|
$51.80B | +6.6% | — | — | 0.0% |
|
JHPCY
Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
|
$45.13B | — | — | — | 0.0% |
|
HLN
Haleon plc
|
$41.40B | -7.0% | — | — | 0.3% |
|
TEVA
Teva Pharmaceutical Industries Ltd
|
$39.45B | +8.6% | +4.3% | — | 2.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| TAK | +1.2% | +5.5% | +1.5% | +0.4% | +2.8% |
| SPY | +1.8% | -1.6% | +7.9% | -1.3% | +9.5% |
| vs SPY | -0.6% | +7.1% | -6.4% | +1.7% | -6.7% |